Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Cornea. 2020 Mar;39(3):311–315. doi: 10.1097/ICO.0000000000002171

Table 3:

Sicca symptoms, signs, and treatment by EMS marker status

EMS positive EMS negative P value
Self-reported dry mouth, % (n) 59.4% (19) 58.3% (7) 0.25
DE symptoms, mean (SD)
 Years with DE symptoms 11.5 (12.5) 10.0 (11.8) 0.74
 DEQ5 (0–22) 16.3 (3.2) 16.1 (2.3) 0.81
 OSDI (0–100) 59.7 (21.2) 57.6 (18.3) 0.80
 Pain intensity (0–10) 1 week recall 5.8 (3.0) 5.3 (2.8) 0.70
 Burning (0–10) 5.0 (3.2) 5.4 (4.4) 0.83
 Sensitivity to wind (0–10) 5.2 (3.1) 5.3 (3.4) 0.98
 Sensitivity to light (0–10) 6.4 (2.9) 5.5 (3.5) 0.53
DE signs, mean (SD)
 Inflammadry* (range 0–3) 1.1 (0.1) 1.5 (0.7) 0.21
 TBUT* (seconds) 4.2 (2.6) 5.7 (4.6) 0.36
 Conjunctivochalasis* (range 0–3) 0.4 (0.4) 0.3 (0.6) 0.61
 Corneal staining* (range 0–15) 5.3 (4.3) 4.2 (3.6) 0.43
  Persistent pain after anesthesia (range 0–10) 2.0 (2.3) 1.9 (2.8) 0.91
 Schirmer score at 5 min* (mm) 5.0 (4.0) 6.5 (5.6) 0.45
Topical medications, % (n)
 Artificial tears 100.0% (32) 83.3% (10) 0.07
 Cyclosporine 100.0% (32) 75.0% (9) 0.02
 Lifitegrast 40.6% (13) 8.3% (1) 0.07
 Ketotifen 18.8% (6) 8.3% (1) 0.65
*

All dry eye signs represent score in the more severely affected eye.

Current or prior

EMS=Early Markers of Sjögren’s; SD=standard deviation; DE=dry eye; DEQ5=Dry Eye Questionnaire 5; OSDI=Ocular Surface Disease Index; TBUT=tear break up time